These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 17911589)

  • 21. Pancreatic infiltration but not diabetes occurs in the relative absence of MHC class II-restricted CD4 T cells: studies using NOD/CIITA-deficient mice.
    Mora C; Wong FS; Chang CH; Flavell RA
    J Immunol; 1999 Apr; 162(8):4576-88. PubMed ID: 10201997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MHC-mismatched islet allografts are vulnerable to autoimmune recognition in vivo.
    Kupfer TM; Crawford ML; Pham K; Gill RG
    J Immunol; 2005 Aug; 175(4):2309-16. PubMed ID: 16081800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes.
    Wicker LS; Appel MC; Dotta F; Pressey A; Miller BJ; DeLarato NH; Fischer PA; Boltz RC; Peterson LB
    J Exp Med; 1992 Jul; 176(1):67-77. PubMed ID: 1613467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone marrow precursors of nonobese diabetic mice develop into defective macrophage-like dendritic cells in vitro.
    Nikolic T; Bunk M; Drexhage HA; Leenen PJ
    J Immunol; 2004 Oct; 173(7):4342-51. PubMed ID: 15383563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RIP-beta 2-microglobulin transgene expression restores insulitis, but not diabetes, in beta 2-microglobulin null nonobese diabetic mice.
    Kay TW; Parker JL; Stephens LA; Thomas HE; Allison J
    J Immunol; 1996 Oct; 157(8):3688-93. PubMed ID: 8871671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-4 triggers autoimmune diabetes by increasing self-antigen presentation within the pancreatic Islets.
    Falcone M; Yeung B; Tucker L; Rodriguez E; Krahl T; Sarvetnick N
    Clin Immunol; 2001 Feb; 98(2):190-9. PubMed ID: 11161975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antigen presentation events during the initiation of autoimmune diabetes in the NOD mouse.
    Ferris ST; Carrero JA; Unanue ER
    J Autoimmun; 2016 Jul; 71():19-25. PubMed ID: 27021276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice.
    Tarbell KV; Petit L; Zuo X; Toy P; Luo X; Mqadmi A; Yang H; Suthanthiran M; Mojsov S; Steinman RM
    J Exp Med; 2007 Jan; 204(1):191-201. PubMed ID: 17210729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subsets of macrophages and dendritic cells in nonobese diabetic mouse pancreatic inflammatory infiltrates: correlation with the development of diabetes.
    Rosmalen JG; Martin T; Dobbs C; Voerman JS; Drexhage HA; Haskins K; Leenen PJ
    Lab Invest; 2000 Jan; 80(1):23-30. PubMed ID: 10652999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and beta-cell destruction in NOD mice.
    Jansen A; Homo-Delarche F; Hooijkaas H; Leenen PJ; Dardenne M; Drexhage HA
    Diabetes; 1994 May; 43(5):667-75. PubMed ID: 8168644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In situ characterization of dendritic cells occurring in the islets of nonobese diabetic mice during the development of insulitis.
    Shinomiya M; Nadano S; Shinomiya H; Onji M
    Pancreas; 2000 Apr; 20(3):290-6. PubMed ID: 10766456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of genetically determined diabetes and insulitis in the nonobese diabetic (NOD) mouse at the level of bone marrow-derived cells. Transfer of diabetes and insulitis to nondiabetic (NOD X B10) F1 mice with bone marrow cells from NOD mice.
    Wicker LS; Miller BJ; Chai A; Terada M; Mullen Y
    J Exp Med; 1988 Jun; 167(6):1801-10. PubMed ID: 3290380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Constitutively active Stat5b signaling confers tolerogenic functions to dendritic cells of NOD mice and halts diabetes progression.
    Zerif E; Maalem A; Gaudreau S; Guindi C; Ramzan M; Véroneau S; Gris D; Stankova J; Rola-Pleszczynski M; Mourad W; Dupuis G; Amrani A
    J Autoimmun; 2017 Jan; 76():63-74. PubMed ID: 27634616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
    Gallichan WS; Balasa B; Davies JD; Sarvetnick N
    J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the roles of CD4+ and CD8+ T cells in autoimmune diabetes of NOD mice using transfer to NOD athymic nude mice.
    Yagi H; Matsumoto M; Kunimoto K; Kawaguchi J; Makino S; Harada M
    Eur J Immunol; 1992 Sep; 22(9):2387-93. PubMed ID: 1516628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor alpha.
    Pakala SV; Chivetta M; Kelly CB; Katz JD
    J Exp Med; 1999 Apr; 189(7):1053-62. PubMed ID: 10190896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of Tolerogenic Dendritic Cells by a PEGylated TLR7 Ligand for Treatment of Type 1 Diabetes.
    Hayashi T; Yao S; Crain B; Promessi VJ; Shyu L; Sheng C; Kang M; Cottam HB; Carson DA; Corr M
    PLoS One; 2015; 10(6):e0129867. PubMed ID: 26076454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A mechanism for IL-10-mediated diabetes in the nonobese diabetic (NOD) mouse: ICAM-1 deficiency blocks accelerated diabetes.
    Balasa B; La Cava A; Van Gunst K; Mocnik L; Balakrishna D; Nguyen N; Tucker L; Sarvetnick N
    J Immunol; 2000 Dec; 165(12):7330-7. PubMed ID: 11120869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Total coumarins from Urtica dentata Hand prevent murine autoimmune diabetes via suppression of the TLR4-signaling pathways.
    Wang J; Lu J; Lan Y; Zhou H; Li W; Xiang M
    J Ethnopharmacol; 2013 Mar; 146(1):379-92. PubMed ID: 23340441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells.
    Gaudreau S; Guindi C; Ménard M; Besin G; Dupuis G; Amrani A
    J Immunol; 2007 Sep; 179(6):3638-47. PubMed ID: 17785799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.